← Back to Search
The Role Of Surface Active Agents In Ophthalmic Drug Delivery: A Comprehensive Review.
Shaimaa S Ibrahim
Published 2019 · Medicine, Chemistry
Download PDFAnalyze on Scholarcy
With the significant advances made in nanotechnology, research efforts focused on developing novel drug delivery platforms that can overcome the multitude of challenges encountered in ophthalmic drug delivery. Surface active agents (SAAs) have been extensively used for the formulation of many of the dosage forms targeting ocular tissues. Novel ophthalmic carriers utilizing SAAs were broadly classified into particulate, vesicular, and controlled release drug delivery systems. Depending on their physicochemical properties, SAAs can perform a variety of roles ranging from wetting agents, emulsifiers, stabilizers, charge inducers, solubilizers, antimicrobial agents, corneal permeation enhancers, and gelling agents. Nevertheless, their use is limited by their potential toxicity and possible interactions with other formulation ingredients. This review provides a comprehensive analysis of the different functional roles of SAAs in novel ophthalmic drug delivery platforms, their mechanism of action, and limitations that need to be considered during formulation to maximize their potential benefit. Understanding the mechanisms by which they perform their different roles and the possible interactions between SAAs and other formulation ingredients can help orientate the choice of formulators toward the SAA most suitable for the intended ocular application at a concentration that is both safe and effective.
This paper references
Surveillance, hygiène et entretien des lentilles de contact☆
L. Bloise (2017)
Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives.
E. Tu (2014)
Development of microemulsions for ocular delivery.
Nivedita Gautam (2017)
Nonionic Surfactant Vesicles in Ocular Delivery: Innovative Approaches and Perspectives
R. K. Sahoo (2014)
Surface properties of mixed phospholipid—stearylamine monolayers and their interaction with a non-ionic surfactant (poloxamer)
D. Korner (1994)
Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers.
P. Calvo (1996)
Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits.
S. Tayel (2013)
Synthetic nanocarriers for the delivery of polynucleotides to the eye
S. Saraiva (2017)
Injectable microspheres with controlled drug release for glaucoma filtering surgery.
H. Kimura (1992)
Ophthalmic Vehicles Containing Polymer-Solubilized Tropicamide: “In Vitro/In Vivo” Evaluation
C. Carmignani (2002)
Adhesion of Positively Charged Liposomes to Mucosal Tissues
L. S. Guo (1989)
Effect of Charged and Non-ionic Membrane Additives on Physicochemical Properties and Stability of Niosomes
V. Junyaprasert (2008)
Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.
Indrajit K. Ghosh (2011)
Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
Jim Jiao (2008)
Ocular Poloxamer-Based Ciprofloxacin Hydrochloride In Situ Forming Gels
M. Mansour (2008)
A Novel Pilocarpine Microemulsion as an Ocular Delivery System: In Vitro and In Vivo Studies
Iskender Ince (2015)
Feasibility of Lipid Nanoparticles for Ocular Delivery of Anti-Inflammatory Drugs
E. Souto (2010)
Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery
I. P. Kaur (2002)
Ciprofloxacin as Ocular Liposomal Hydrogel
K. Hosny (2009)
The delivery and antinociceptive effects of morphine and its ester prodrugs from lipid emulsions.
J. Wang (2008)
Voriconazole-Loaded Nanostructured Lipid Carriers for Ocular Drug Delivery
L. M. Andrade (2016)
Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy.
T. Moritera (1992)
Spanlastics--a novel nanovesicular carrier system for ocular delivery.
S. Kakkar (2011)
Top ten considerations in the development of parenteral emulsions.
Ocular Self-Microemulsifying Drug Delivery System of Prednisolone Improves Therapeutic Effectiveness in the Treatment of Experimental Uveitis
R. Tiwari (2019)
Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
M. Kassem (2007)
Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.
A. D. Vadlapudi (2014)
Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis
S. Malhotra (2014)
Ocular Delivery System for Propranolol Hydrochloride Based on Nanostructured Lipid Carrier
Behzad Sharif Makhmal Zadeh (2018)
Surfactants: Pharmaceutical and Medicinal Aspects
B. S. Sekhon (2013)
Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.
K. Cholkar (2012)
NANOTECHNOLOGY: A NEW APPROACH FOR OCULAR DRUG DELIVERY SYSTEM
Meetali Mudgil (2012)
Selective Antimicrobial Activities and Action Mechanism of Micelles Self-Assembled by Cationic Oligomeric Surfactants.
C. Zhou (2016)
Investigation on Processing Variables for the Preparation of Fluconazole-Loaded Ethyl Cellulose Microspheres by Modified Multiple Emulsion Technique
Sabyasachi Maiti (2009)
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery
C. Puglia (2018)
Cyclosporine A Formulation Affects Its Ocular Distribution in Rabbits
M. Kuwano (2004)
Evaluation of ocular permeation enhancers: In vitro effects on corneal transport of four β-blockers, and in vitro/in vivo toxic activity
M. Saettone (1996)
Engineering of polymer–surfactant nanoparticles of doxycycline hydrochloride for ocular drug delivery
V. Pokharkar (2015)
Advances in ocular drug delivery: emphasis on the posterior segment
Jennifer J. Kang-Mieler (2014)
Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts
F. Lallemand (2017)
New Techniques for Drug Delivery to the Posterior Eye Segment
E. Eljarrat-Binstock (2009)
Ocular toxicity of some corneal penetration enhancers evaluated by electrophysiology measurements on isolated rabbit corneas.
P. Chetoni (2003)
Recent Advances in the Application of Vitamin E TPGS for Drug Delivery
Conglian Yang (2018)
Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability
S. Han (2010)
Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants.
P. Furrer (2000)
Prediction of Eye Irritation Potential of Surfactant-Based Rinse-Off Personal Care Formulations by the Bovine Corneal Opacity and Permeability (BCOP) Assay
K. C. Cater (2006)
Recent patents on ophthalmic nanoformulations and therapeutic implications.
Ann-Marie Ako-Adounvo (2014)
Comparative effects of different cosurfactants on sterile prednisolone acetate ocular submicron emulsions stability and release.
Shaimaa S Ibrahim (2009)
Colloidal drug delivery system: amplify the ocular delivery
Nanotechnology in ocular drug delivery.
S. Sahoo (2008)
Further investigation of nanostructured lipid carriers as an ocular delivery system: in vivo transcorneal mechanism and in vitro release study.
Bao-Cheng Tian (2013)
Non-invasive strategies for targeting the posterior segment of eye.
Asadullah Madni (2017)
Preparation and ocular pharmacokinetics of ganciclovir liposomes
Y. Shen (2008)
Ocular delivery of cyclosporin A. II. Effect of submicron emulsion's surface charge on ocular distribution of topical cyclosporin A
M. Abdulrazik (2001)
Design of liposomal colloidal systems for ocular delivery of ciprofloxacin.
E. Taha (2014)
Pharmacosomes: An Emerging Novel Vesicular Drug Delivery System for Poorly Soluble Synthetic and Herbal Drugs
Archana Pandita (2013)
Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B
W. Zhou (2013)
Micellar solutions of triblock copolymer surfactants with pilocarpine.
I. Pepić (2004)
Surfactant-laden soft contact lenses for extended delivery of ophthalmic drugs.
Yash Kapoor (2009)
Characterization and In‐vivo Ocular Absorption of Liposome‐encapsulated Acyclovir
M. Fresta (1999)
Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery.
M. Nagarsenker (1999)
Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants
V. Iyer (2015)
Vehicle effects on ophthalmic bioavailability: the influence of different polymers on the activity of pilocarpine in rabbit and man
M. Saettone (1982)
Discoidal niosome based controlled ocular delivery of timolol maleate.
S. Vyas (1998)
Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery
G. Abdelbary (2008)
In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate.
A. El-Kamel (2002)
The role of surfactants in multipurpose solutions
Valerie Franklin (2013)
Effect of hydrophilic polymers on the wettability, static and dynamic, of solid substrate covered by confluent monolayer of air-damaged SIRC cells
Petar Eftimov (2015)
Mucoadhesive self-emulsifying delivery systems for ocular administration of econazole.
Ibrahim A. Elbahwy (2018)
In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery.
Kosai Al Khateb (2016)
Microemulsions as ocular drug delivery systems: recent developments and future challenges
T. Vandamme (2002)
Poloxamer 407/TPGS Mixed Micelles as Promising Carriers for Cyclosporine Ocular Delivery.
M. A. Grimaudo (2018)
Nonionic surfactant vesicular systems for effective drug delivery—an overview
G. P. Kumar (2011)
Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery
H. Ammar (2010)
The role of surfactant in controlling particle size and stability in the miniemulsion polymerization of polymeric nanocapsules
A. V. Zyl (2004)
A novel eye drop of alpha tocopherol to prevent ocular oxidant damage: improve the stability and ocular efficacy
Jiayu Xin (2016)
Nanoemulsion as a Potential Ophthalmic Delivery System for Dorzolamide Hydrochloride
H. Ammar (2009)
Preservatives in eyedrops: The good, the bad and the ugly
C. Baudouin (2010)
Sustained release of intravitreal flurbiprofen from a novel drug‐in‐liposome‐in‐hydrogel formulation☆
K. Pachis (2017)
Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium.
C. Yong (2001)
The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: implications for drug delivery.
Murray S. Webb (1995)
Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications
Saurabh Bhatia (2016)
Polymers used in ocular dosage form and drug delivery systems
V. Wagh (2008)
Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems.
S. Tamilvanan (2004)
Application of a drug delivery system to a steroidal ophthalmic preparation with lipid microspheres.
A. Yanagawa (1987)
Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits
H. Liang (2008)
Impact of surface tension in pharmaceutical sciences.
Anahita Fathi Azarbayjani (2009)
Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate
X. Yang (2015)
Colloidal carriers for ophthalmic drug delivery.
R. Mainardes (2005)
Mucoadhesive dexamethasone acetate-polymyxin B sulfate cationic ocular nanoemulsion--novel combinatorial formulation concept.
Xia Li (2016)
Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview
H. Almeida (2013)
Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Jiayuan Huang (2017)
Vesicular systems in ocular drug delivery: an overview.
I. P. Kaur (2004)
Intraocular implants for extended drug delivery: therapeutic applications.
J. Bourges (2006)
Ocular and dermal irritation studies of some quaternary ammonium compounds.
Guang Hai Lin (1996)
Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes.
A. Manosroi (2010)
Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation.
J. Fangueiro (2014)
Performance of some Surfactants as Wetting Agents
M. N. Shalaby (2005)
Physicochemical Characterization and Acute Toxicity Evaluation of a Positively‐charged Submicron Emulsion Vehicle
S. Klang (1994)
Prediction of Eye Irritation Potential of Surfactants using the SIRC-NRU Cytotoxicity Test
R. Roguet (1992)
The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs.
Sung-hyun Park (2006)
Ocular disposition of inulin from single & multiple doses of positively charged multilamellar liposomes: evidence for alterations in tear dynamics and ocular surface characteristics.
V. Lee (1986)
This paper is referenced by
Voriconazole-loaded self-nanoemulsifying drug delivery system (SNEDDS) to improve transcorneal permeability
Bakoliarisoa Nivomalala Voahangy Rasoanirina (2020)
Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: improved pharmacokinetic/pharmacodynamic properties.
Ayman Ismail (2020)
Self‐nanoemulsifying drug delivery system to improve transcorneal permeability of voriconazole: in‐vivo studies
Bakoliarisoa Nivomalala Voahangy Rasoanirina (2020)
Fabrication of Transgelosomes for Enhancing the Ocular Delivery of Acetazolamide: Statistical Optimization, In Vitro Characterization, and In Vivo Study
Eman A. Mazyed (2020)
Understanding polysorbate-compound interactions within the CMC region.
Laura J Waters (2020)
Amphiphilic Acrylic Nanoparticles Containing the Poloxamer Star Bayfit® 10WF15 as Ophthalmic Drug Carriers
Miguel Gómez-Ballesteros (2019)